247 related articles for article (PubMed ID: 9735086)
1. Management of pituitary tumors.
Shimon I; Melmed S
Ann Intern Med; 1998 Sep; 129(6):472-83. PubMed ID: 9735086
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and Treatment of Pituitary Adenomas: A Review.
Molitch ME
JAMA; 2017 Feb; 317(5):516-524. PubMed ID: 28170483
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of pituitary adenomas].
Mezosi E; Nemes O
Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
[TBL] [Abstract][Full Text] [Related]
5. Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature.
Kienitz T; Quinkler M; Strasburger CJ; Ventz M
Eur J Endocrinol; 2007 Jul; 157(1):39-46. PubMed ID: 17609400
[TBL] [Abstract][Full Text] [Related]
6. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
Socin HV; Chanson P; Delemer B; Tabarin A; Rohmer V; Mockel J; Stevenaert A; Beckers A
Eur J Endocrinol; 2003 Apr; 148(4):433-42. PubMed ID: 12656664
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
8. Effects of medical therapy on pituitary tumors.
Kovacs K; Horvath E
Ultrastruct Pathol; 2005; 29(3-4):163-7. PubMed ID: 16036872
[TBL] [Abstract][Full Text] [Related]
9. Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
Lambert K; Rees K; Seed PT; Dhanjal MK; Knight M; McCance DR; Williamson C
Obstet Gynecol; 2017 Jan; 129(1):185-194. PubMed ID: 27926659
[TBL] [Abstract][Full Text] [Related]
10. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
Iglesias P; Díez JJ
J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
[TBL] [Abstract][Full Text] [Related]
11. Effects of cabergoline in a pituitary adenoma secreting follicle-stimulating hormone.
Leese G; Jeffreys R; Vora J
Postgrad Med J; 1997 Aug; 73(862):507-8. PubMed ID: 9307745
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy.
Losa M; Fortunato M; Molteni L; Peretti E; Mortini P
Minerva Endocrinol; 2008 Dec; 33(4):329-40. PubMed ID: 18923369
[TBL] [Abstract][Full Text] [Related]
13. [Novel pharmacologic therapies in acromegaly].
Góth M; Hubina E; Kovács L; Szabolcs I
Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
[TBL] [Abstract][Full Text] [Related]
14. Medical management of growth hormone-secreting pituitary adenomas.
Racine MS; Barkan AL
Pituitary; 2002; 5(2):67-76. PubMed ID: 12675503
[TBL] [Abstract][Full Text] [Related]
15. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
16. Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment.
Sanno N; Teramoto A; Osamura RY
J Neurooncol; 2001 Sep; 54(2):179-86. PubMed ID: 11761434
[TBL] [Abstract][Full Text] [Related]
17. [Pituitary adenomas--where is the treatment heading at the beginning of the 21st century?].
Marek J
Vnitr Lek; 2010 Jul; 56(7):690-4. PubMed ID: 20842914
[TBL] [Abstract][Full Text] [Related]
18. Dopamine agonists and pituitary tumor shrinkage.
Bevan JS; Webster J; Burke CW; Scanlon MF
Endocr Rev; 1992 May; 13(2):220-40. PubMed ID: 1352243
[TBL] [Abstract][Full Text] [Related]
19. New medical approaches in pituitary adenomas.
Colao A; Di Sarno A; Marzullo P; Di Somma C; Cerbone G; Landi ML; Faggiano A; Merola B; Lombardi G
Horm Res; 2000; 53 Suppl 3():76-87. PubMed ID: 10971110
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours.
Colao A; Filippella M; Pivonello R; Di Somma C; Faggiano A; Lombardi G
Eur J Endocrinol; 2007 Apr; 156 Suppl 1():S57-S63. PubMed ID: 17413190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
